Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank64
5Y CAGR-36.1%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
-36.1%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 13.20% |
| Q2 2025 | 28.87% |
| Q1 2025 | 5.60% |
| Q4 2024 | -1.77% |
| Q3 2024 | 6.45% |
| Q2 2024 | 3.15% |
| Q1 2024 | 25.50% |
| Q4 2023 | 14.46% |
| Q3 2023 | -16.98% |
| Q2 2023 | -1.89% |
| Q1 2023 | 18.19% |
| Q4 2022 | -19.80% |
| Q3 2022 | -18.18% |
| Q2 2022 | -11.37% |
| Q1 2022 | 17.97% |
| Q4 2021 | -5.40% |
| Q3 2021 | -92.92% |
| Q2 2021 | -38.99% |
| Q1 2021 | 40.38% |
| Q4 2020 | -1138.21% |
| Q3 2020 | 123.49% |
| Q2 2020 | 59.38% |
| Q1 2020 | 0.00% |